Pavadi Capital LLC Fulgent Genetics, Inc. Transaction History

Pavadi Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$37.92 - $63.74 $271,203 - $455,868	-7,152 Reduced 8.8%	74,125 $2.83 Million
Q2 2022 Aug 15, 2022	BUY	$47.98 - $62.75 $621,053 - $812,236	12,944 Added 18.94%	81,277 $4.43 Million
Q1 2022 May 16, 2022	SELL	$49.85 - $96.11 $315,450 - $608,184	-6,328 Reduced 8.48%	68,333 $4.27 Million
Q4 2021 Feb 14, 2022	BUY	$77.3 - $105.0 $5.77 Million - $7.84 Million	74,661 New	74,661 $7.51 Million

198

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $504M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Pavadi Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Pavadi Capital LLC with notifications on news.